hVIVO PLC (HVO)

Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

8.10p

Buy

8.40p

arrow-down-0.20p (-2.37%)

Prices updated at 15 Jun 2026, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
hVIVO PLC is a full-service early phase Contract Research Organisation (CRO). It delivers end-to-end clinical development services to a diverse and expanding client base. The group specialises in conducting human challenge trials across multiple infec ...
FTSE All-Share
arrow-down-0.33%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.

Most recent dividend payment

0.002
Cash Dividend
15 May 2025
10 Apr 2025
16 May 2025
11 Jun 2025

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
2026--
20250.0020-
20240.0020-
20230.0045-
2022--
2021--
2020--
2019--
2018--
2017--

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20263.17-
20253.17-
20240.98-
2023--
2022--
2021--
2020--
2019--
2018--
2017--

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
2026-
20250.0020
20240.0020
20230.0045
2022-
2021-
2020-
2019-
2018-
2017-

% of earnings paid to shareholders data table

YearPayout ratio (%)
202625.97
202525.97
20247.91
2023-
2022-
2021-
2020-
2019-
2018-
2017-
Latest Financial Report as of 12 Jun 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.